RecruitingNot ApplicableNCT04874259

LT for Unresectable Colorectal Liver Metastasis

Effectiveness of Liver Transplantation for Unresectable Colorectal Liver Metastasis; Pilot Study


Sponsor

Seoul National University Hospital

Enrollment

20 participants

Start Date

Aug 22, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Unlike hepatocellular carcinoma, liver transplantation in patients with liver metastasis from colorectal cancer is limited in only few centers. Previously, it was not generally implemented due to lack of organs and high recurrence rates after transplantation. However, due to progressive development in treatments, good results such as increased survival rates can be expected even in liver transplant patients with liver metastasis from colorectal cancer, which is known to have poor prognosis. Therefore, the purpose of this study is to analyze the efficacy of liver transplantation as an alternative treatment for liver metastasis from colorectal cancer.


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This trial explores liver transplantation as a treatment option for patients with colorectal cancer that has spread only to the liver and cannot be surgically removed. A living donor is needed. Currently, liver transplant for this condition is experimental, but early data suggests it may offer longer survival than other treatments. **You may be eligible if...** - You have confirmed colorectal cancer spread to the liver only, with no other sites of spread - Your liver metastases cannot be removed surgically and you have not yet had other treatments such as chemotherapy or immunotherapy - A multidisciplinary team has selected you as a suitable transplant candidate - You have a willing, healthy living donor - You are able to provide written informed consent **You may NOT be eligible if...** - You are pregnant - You have HIV - You have an active peptic ulcer within 2 weeks of transplant - Your original colon cancer is still active after colon resection - You are hemodynamically unstable (your blood pressure or circulation is not stable) - Your liver metastases have progressed at any point before the transplant surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELiving donor liver transplantation

Living donor liver transplantation


Locations(1)

Seoul National University Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04874259


Related Trials